{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:27:35Z","timestamp":1760956055347,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS110828"],"award-info":[{"award-number":["K23NS110828"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12028-020-01093-0","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T23:19:48Z","timestamp":1600125588000},"page":"650-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Commentary on TNF-R1 Correlates with Cerebral Perfusion and Acute Ischemia Following Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1598-9782","authenticated-orcid":false,"given":"H. E.","family":"Hinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.wneu.2010.02.005","volume":"73","author":"YZ Al-Tamimi","year":"2010","unstructured":"Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg. 2010;73:654\u201367.","journal-title":"World Neurosurg"},{"key":"1093_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.2310\/JIM.0b013e3182686932","volume":"60","author":"SH-Y Chou","year":"2012","unstructured":"Chou SH-Y, Feske SK, Atherton J, Konigsberg RG, De Jager PL, Du R, et al. Early elevation of serum tumor necrosis factor-\u03b1 is associated with poor outcome in subarachnoid hemorrhage. J Investig Med. 2012;60:1054\u20138.","journal-title":"J Investig Med"},{"key":"1093_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3171\/jns.1997.87.2.0215","volume":"87","author":"T Mathiesen","year":"1997","unstructured":"Mathiesen T, Edner G, Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg. 1997;87:215\u201320.","journal-title":"J Neurosurg"},{"key":"1093_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12028-019-00669-9","volume":"31","author":"I Fragata","year":"2019","unstructured":"Fragata I, Bustamante A, Penalba A, Ferreira P, Nunes AP, Canh\u00e3o P, et al. Venous and arterial TNF-R1 predicts outcome and complications in acute subarachnoid hemorrhage. Neurocrit Care. 2019;31:107\u201315.","journal-title":"Neurocrit Care"},{"key":"1093_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/157488612803251315","volume":"7","author":"AMH Young","year":"2012","unstructured":"Young AMH, Karri SK, You W, Ogilvy CS. Specific TNF-alpha inhibition in cerebral aneurysm formation and subarachnoid hemorrhage. Curr Drug Saf. 2012;7:190\u20136.","journal-title":"Curr Drug Saf"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-01093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-020-01093-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-01093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T01:23:48Z","timestamp":1631669028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-020-01093-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1007\/s12028-020-01093-0","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"type":"print","value":"1541-6933"},{"type":"electronic","value":"1556-0961"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Hinson reports  and Consulting work for Biogen on a stroke trial (Phase 3 CHARM trial). One-time consulting fee from IschemaView. Editorial work for the journal \u201cNeurology\u201d.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}